About: ABIVAX Société Anonyme, a clinical-stage biotechnology company, develops therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. Its lead drug candidate includes obefazimod, which is in Phase 3 clinical development for the treatment of moderately to severely active UC, as well as Phase 2b clinical trials for Crohn's disease. The company was incorporated in 2013 and is headquartered in Paris, France.
Sector: Healthcare
Industry: Biotechnology
Latest price: $89.06 (-0.87%)
ABVX NASDAQ Abivax SA American Depositary Shares
Abivax SA American Depositary Shares share price
Atividade de preço de ABVX
Último preço
$ 89,060
Variação (24h)
-0,78 USD (0,87%)
Volume
592.15K
Volume (média 4 sem.)
-
Abertura
$ 89,85
Variação do dia
$ 88,39 - $ 92,08
Fechamento anterior
$ 89,84
Último negócio
29 Oct, 8:00 pm GMT+0
Atrasado
29 Oct, 8:00 pm GMT+0
ABVX price performance
Atrasado
29 Oct, 8:00 pm GMT+0
quote.marketSignals